Wall Street Analysts Believe BioCryst (BCRX) Could Rally 55.81%: Here's is How to Trade

  • The mean of analysts' price targets for BioCryst (BCRX) points to a 55.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.